Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease

Authors: José Portolés, Jose Luis Gorriz, Esther Rubio, Fernando de Alvaro, Florencio García, Vicente Alvarez-Chivas, Pedro Aranda, Alberto Martinez-Castelao, NADIR-3 Study Group

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Anemia is a common condition in CKD that has been identified as a cardiovascular (CV) risk factor in end-stage renal disease, constituting a predictor of low survival. The aim of this study was to define the onset of anemia of renal origin and its association with the evolution of kidney disease and clinical outcomes in stage 3 CKD (CKD-3).

Methods

This epidemiological, prospective, multicenter, 3-year study included 439 CKD-3 patients. The origin of nephropathy and comorbidity (Charlson score: 3.2) were recorded. The clinical characteristics of patients that developed anemia according to EBPG guidelines were compared with those that did not, followed by multivariate logistic regression, Kaplan-Meier curves and ROC curves to investigate factors associated with the development of renal anemia.

Results

During the 36-month follow-up period, 50% reached CKD-4 or 5, and approximately 35% were diagnosed with anemia (85% of renal origin). The probability of developing renal anemia was 0.12, 0.20 and 0.25 at 1, 2 and 3 years, respectively. Patients that developed anemia were mainly men (72% anemic vs. 69% non-anemic). The mean age was 68 vs. 65.5 years and baseline proteinuria was 0.94 vs. 0.62 g/24h (anemic vs. non anemic, respectively). Baseline MDRD values were 36 vs. 40 mL/min and albumin 4.1 vs. 4.3 g/dL; reduction in MDRD was greater in those that developed anemia (6.8 vs. 1.6 mL/min/1.73 m2/3 years). These patients progressed earlier to CKD-4 or 5 (18 vs. 28 months), with a higher proportion of hospitalizations (31 vs. 16%), major CV events (16 vs. 7%), and higher mortality (10 vs. 6.6%) than those without anemia. Multivariate logistic regression indicated a significant association between baseline hemoglobin (OR=0.35; 95% CI: 0.24-0.28), glomerular filtration rate (OR=0.96; 95% CI: 0.93-0.99), female (OR=0.19; 95% CI: 0.10-0.40) and the development of renal anemia.

Conclusions

Renal anemia is associated with a more rapid evolution to CKD-4, and a higher risk of CV events and hospitalization in non-dialysis-dependent CKD patients. This suggests that special attention should be paid to anemic CKD-3 patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Whaley-Connell A, Sowers JR, McCullough PA, Roberts T, McFarlane SI, Chen SC, Li S, Wang C, Collins AJ, Bakris GL: Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES). Am J Kidney Dis. 2009, 53 (4 Suppl 4): S11-S21.CrossRefPubMed Whaley-Connell A, Sowers JR, McCullough PA, Roberts T, McFarlane SI, Chen SC, Li S, Wang C, Collins AJ, Bakris GL: Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES). Am J Kidney Dis. 2009, 53 (4 Suppl 4): S11-S21.CrossRefPubMed
2.
go back to reference Coresh J, Astor B, Sarnak MJ: Evidence for increased cardiovascular disease risk in patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2004, 13 (1): 73-81. 10.1097/00041552-200401000-00011.CrossRefPubMed Coresh J, Astor B, Sarnak MJ: Evidence for increased cardiovascular disease risk in patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2004, 13 (1): 73-81. 10.1097/00041552-200401000-00011.CrossRefPubMed
3.
go back to reference Otero A, de Francisco A, Gayoso P, Garcia F: Prevalence of chronic renal disease in Spain: results of the EPIRCE study. Nefrologia. 2010, 30 (1): 78-86.PubMed Otero A, de Francisco A, Gayoso P, Garcia F: Prevalence of chronic renal disease in Spain: results of the EPIRCE study. Nefrologia. 2010, 30 (1): 78-86.PubMed
4.
go back to reference ERA/EDTA: Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure. Anaemia evaluation. Nephrol Dial Transplant. 2004, 19 (Suppl. 2): ii2-ii5. ERA/EDTA: Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure. Anaemia evaluation. Nephrol Dial Transplant. 2004, 19 (Suppl. 2): ii2-ii5.
5.
go back to reference Stancu S, Barsan L, Stanciu A, Mircescu G: Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease?. Clin J Am Soc Nephrol. 2010, 5 (3): 409-416. 10.2215/CJN.04280609.CrossRefPubMedPubMedCentral Stancu S, Barsan L, Stanciu A, Mircescu G: Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease?. Clin J Am Soc Nephrol. 2010, 5 (3): 409-416. 10.2215/CJN.04280609.CrossRefPubMedPubMedCentral
6.
go back to reference Meuwese CL, Stenvinkel P, Dekker FW, Carrero JJ: Monitoring of inflammation in patients on dialysis: forewarned is forearmed. Nat Rev Nephrol. 2011, 7 (3): 166-176. 10.1038/nrneph.2011.2.CrossRefPubMed Meuwese CL, Stenvinkel P, Dekker FW, Carrero JJ: Monitoring of inflammation in patients on dialysis: forewarned is forearmed. Nat Rev Nephrol. 2011, 7 (3): 166-176. 10.1038/nrneph.2011.2.CrossRefPubMed
7.
go back to reference Chen N, Wang W, Huang Y, Shen P, Pei D, Yu H, Shi H, Zhang Q, Xu J, Lv Y: Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant. 2009, 24 (7): 2117-2123. 10.1093/ndt/gfn767.CrossRefPubMedPubMedCentral Chen N, Wang W, Huang Y, Shen P, Pei D, Yu H, Shi H, Zhang Q, Xu J, Lv Y: Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant. 2009, 24 (7): 2117-2123. 10.1093/ndt/gfn767.CrossRefPubMedPubMedCentral
8.
go back to reference Astor BC, Muntner P, Levin A, Eustace JA, Coresh J: Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988–1994). Arch Intern Med. 2002, 162 (12): 1401-1408. 10.1001/archinte.162.12.1401.CrossRefPubMed Astor BC, Muntner P, Levin A, Eustace JA, Coresh J: Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988–1994). Arch Intern Med. 2002, 162 (12): 1401-1408. 10.1001/archinte.162.12.1401.CrossRefPubMed
9.
go back to reference Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH: Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005, 16 (1): 180-188.CrossRefPubMed Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH: Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005, 16 (1): 180-188.CrossRefPubMed
10.
go back to reference Shaheen FA, Souqiyyeh MZ, Al-Attar BA, Karkar A, Al Jazairi AM, Badawi LS, Ballut OM, Hakami AH, Naguib M, Al-Homrany MA: Prevalence of anemia in predialysis chronic kidney disease patients. Saudi J Kidney Dis Transpl. 2011, 22 (3): 456-463.PubMed Shaheen FA, Souqiyyeh MZ, Al-Attar BA, Karkar A, Al Jazairi AM, Badawi LS, Ballut OM, Hakami AH, Naguib M, Al-Homrany MA: Prevalence of anemia in predialysis chronic kidney disease patients. Saudi J Kidney Dis Transpl. 2011, 22 (3): 456-463.PubMed
11.
go back to reference Singh AK: The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis. Clin J Am Soc Nephrol. 2010, 5 (4): 553-556. 10.2215/CJN.00490110.CrossRefPubMed Singh AK: The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis. Clin J Am Soc Nephrol. 2010, 5 (4): 553-556. 10.2215/CJN.00490110.CrossRefPubMed
12.
go back to reference Charlson M, Szatrowski TP, Peterson J, Gold J: Validation of a combined comorbidity index. J Clin Epidemiol. 1994, 47 (11): 1245-1251. 10.1016/0895-4356(94)90129-5.CrossRefPubMed Charlson M, Szatrowski TP, Peterson J, Gold J: Validation of a combined comorbidity index. J Clin Epidemiol. 1994, 47 (11): 1245-1251. 10.1016/0895-4356(94)90129-5.CrossRefPubMed
13.
go back to reference Akizawa T, Makino H, Matsuo S, Watanabe T, Imai E, Nitta K, Ohashi Y, Hishida A: Management of anemia in chronic kidney disease patients: baseline findings from Chronic Kidney Disease Japan Cohort Study. Clin Exp Nephrol. 2011, 15 (2): 248-257. 10.1007/s10157-010-0396-7.CrossRefPubMed Akizawa T, Makino H, Matsuo S, Watanabe T, Imai E, Nitta K, Ohashi Y, Hishida A: Management of anemia in chronic kidney disease patients: baseline findings from Chronic Kidney Disease Japan Cohort Study. Clin Exp Nephrol. 2011, 15 (2): 248-257. 10.1007/s10157-010-0396-7.CrossRefPubMed
14.
go back to reference Portoles J, Castelao AM, Gorriz JL, Tato AM, de Alvaro F: Anemia development and cardiovascular risk management in nonanemic stage 3 chronic kidney disease. Ren Fail. 2009, 31 (10): 869-875. 10.3109/08860220903216063.CrossRefPubMed Portoles J, Castelao AM, Gorriz JL, Tato AM, de Alvaro F: Anemia development and cardiovascular risk management in nonanemic stage 3 chronic kidney disease. Ren Fail. 2009, 31 (10): 869-875. 10.3109/08860220903216063.CrossRefPubMed
15.
go back to reference Del Fabbro P, Luthi JC, Carrera E, Michel P, Burnier M, Burnand B: Anemia and chronic kidney disease are potential risk factors for mortality in stroke patients: a historic cohort study. BMC Nephrol. 2010, 11: 27-10.1186/1471-2369-11-27.CrossRefPubMedPubMedCentral Del Fabbro P, Luthi JC, Carrera E, Michel P, Burnier M, Burnand B: Anemia and chronic kidney disease are potential risk factors for mortality in stroke patients: a historic cohort study. BMC Nephrol. 2010, 11: 27-10.1186/1471-2369-11-27.CrossRefPubMedPubMedCentral
16.
go back to reference Anderson J, Glynn LG, Newell J, Iglesias AA, Reddan D, Murphy AW: The impact of renal insufficiency and anaemia on survival in patients with cardiovascular disease: a cohort study. BMC Cardiovasc Disord. 2009, 9: 51-10.1186/1471-2261-9-51.CrossRefPubMedPubMedCentral Anderson J, Glynn LG, Newell J, Iglesias AA, Reddan D, Murphy AW: The impact of renal insufficiency and anaemia on survival in patients with cardiovascular disease: a cohort study. BMC Cardiovasc Disord. 2009, 9: 51-10.1186/1471-2261-9-51.CrossRefPubMedPubMedCentral
17.
go back to reference Staples AO, Wong CS, Smith JM, Gipson DS, Filler G, Warady BA, Martz K, Greenbaum LA: Anemia and risk of hospitalization in pediatric chronic kidney disease. Clin J Am Soc Nephrol. 2009, 4 (1): 48-56. 10.2215/CJN.05301107.CrossRefPubMedPubMedCentral Staples AO, Wong CS, Smith JM, Gipson DS, Filler G, Warady BA, Martz K, Greenbaum LA: Anemia and risk of hospitalization in pediatric chronic kidney disease. Clin J Am Soc Nephrol. 2009, 4 (1): 48-56. 10.2215/CJN.05301107.CrossRefPubMedPubMedCentral
18.
go back to reference Atkinson MA, Martz K, Warady BA, Neu AM: Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS. Pediatr Nephrol. 2010, 25 (9): 1699-1706. 10.1007/s00467-010-1538-6.CrossRefPubMed Atkinson MA, Martz K, Warady BA, Neu AM: Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS. Pediatr Nephrol. 2010, 25 (9): 1699-1706. 10.1007/s00467-010-1538-6.CrossRefPubMed
19.
go back to reference Rasic-Milutinovic Z, Perunicic G, Pljesa S, Gluvic Z, Ilic M, Stokic E: The effect of nutritional status, body composition, inflammation and serum iron on the developement of insulin resistance among patients on long-term hemodialysis. Med Pregl. 2007, 60 (Suppl 2): 33-38.PubMed Rasic-Milutinovic Z, Perunicic G, Pljesa S, Gluvic Z, Ilic M, Stokic E: The effect of nutritional status, body composition, inflammation and serum iron on the developement of insulin resistance among patients on long-term hemodialysis. Med Pregl. 2007, 60 (Suppl 2): 33-38.PubMed
20.
go back to reference Farag YM, Keithi-Reddy SR, Mittal BV, Surana SP, Addabbo F, Goligorsky MS, Singh AK: Anemia, inflammation and health-related quality of life in chronic kidney disease patients. Clin Nephrol. 2011, 75 (6): 524-533.CrossRefPubMed Farag YM, Keithi-Reddy SR, Mittal BV, Surana SP, Addabbo F, Goligorsky MS, Singh AK: Anemia, inflammation and health-related quality of life in chronic kidney disease patients. Clin Nephrol. 2011, 75 (6): 524-533.CrossRefPubMed
21.
go back to reference Levin A: Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge. Kidney Int Suppl. 2002, 80: 35-38.CrossRefPubMed Levin A: Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge. Kidney Int Suppl. 2002, 80: 35-38.CrossRefPubMed
22.
go back to reference De Nicola L, Minutolo R, Chiodini P, Zamboli P, Cianciaruso B, Nappi F, Signoriello S, Conte G, Zoccali C, Group S-TCS: Prevalence and prognosis of mild anemia in non-dialysis chronic kidney disease: a prospective cohort study in outpatient renal clinics. Am J Nephrol. 2010, 32 (6): 533-540. 10.1159/000321468.CrossRefPubMed De Nicola L, Minutolo R, Chiodini P, Zamboli P, Cianciaruso B, Nappi F, Signoriello S, Conte G, Zoccali C, Group S-TCS: Prevalence and prognosis of mild anemia in non-dialysis chronic kidney disease: a prospective cohort study in outpatient renal clinics. Am J Nephrol. 2010, 32 (6): 533-540. 10.1159/000321468.CrossRefPubMed
23.
go back to reference Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, Iimuro S, Ohashi Y, Hishida A: Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol. 2010, 14 (6): 558-570. 10.1007/s10157-010-0328-6.CrossRefPubMed Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, Iimuro S, Ohashi Y, Hishida A: Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol. 2010, 14 (6): 558-570. 10.1007/s10157-010-0328-6.CrossRefPubMed
24.
go back to reference Locatelli F, Pisoni RL, Combe C, Bommer J, Andreucci VE, Piera L, Greenwood R, Feldman HI, Port FK, Held PJ: Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2004, 19 (1): 121-132. 10.1093/ndt/gfg458.CrossRefPubMed Locatelli F, Pisoni RL, Combe C, Bommer J, Andreucci VE, Piera L, Greenwood R, Feldman HI, Port FK, Held PJ: Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2004, 19 (1): 121-132. 10.1093/ndt/gfg458.CrossRefPubMed
25.
go back to reference McClellan W, Aronoff SL, Bolton WK, Hood S, Lorber DL, Tang KL, Tse TF, Wasserman B, Leiserowitz M: The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin. 2004, 20 (9): 1501-1510. 10.1185/030079904X2763.CrossRefPubMed McClellan W, Aronoff SL, Bolton WK, Hood S, Lorber DL, Tang KL, Tse TF, Wasserman B, Leiserowitz M: The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin. 2004, 20 (9): 1501-1510. 10.1185/030079904X2763.CrossRefPubMed
26.
go back to reference Portoles J, Lopez-Gomez JM, Aljama P: A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study. Nephrol Dial Transplant. 2007, 22 (2): 500-507.CrossRefPubMed Portoles J, Lopez-Gomez JM, Aljama P: A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study. Nephrol Dial Transplant. 2007, 22 (2): 500-507.CrossRefPubMed
Metadata
Title
The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease
Authors
José Portolés
Jose Luis Gorriz
Esther Rubio
Fernando de Alvaro
Florencio García
Vicente Alvarez-Chivas
Pedro Aranda
Alberto Martinez-Castelao
NADIR-3 Study Group
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-2

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.